This article was originally published in The Gray Sheet
Executive SummaryAnnounces a 4-for-3 common stock split to be payable on or about Sept. 14 to all shareholders of record as of Sept. 6. The split, announced Aug. 25, will increase the number of shares outstanding to 12.3 mil. and will reduce the stock's price per share by 33.3%. Healthdyne Technologies is an 81%-owned subsidiary of Healthdyne, Inc
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.